← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vaxine Pty Ltd
Bedford Park
$31,064,495
Total funding
4
Grants
Funding over time
peak $7.7M · FY2009–22$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$31,064,495 · 4
By mechanism
N01$31,064,495 · 4
Investigators at Vaxine Pty Ltd
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
High-throughput screening for novel adjuvant discovery for vaccines against influenza virus$7,748,631
N01 · FY2014 · AI
Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases$3,532,876
N01 · FY2020 · AI
Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases$2,835,478
N01 · FY2018 · AI
Adjuvant Development in the context of a vaccine to protect against tuberculosis$2,494,333
N01 · FY2018 · AI
High-throughput screening for novel adjuvant discovery for vaccines against influenza virus$1,904,860
N01 · FY2018 · AI
Adjuvant Development Program$1,886,967
N01 · FY2010 · AI
Adjuvant Development Program$1,830,015
N01 · FY2011 · AI
Adjuvant Development Program$1,748,502
N01 · FY2009 · AI
Adjuvant Development in the context of a vaccine to protect against tuberculosis$1,551,986
N01 · FY2022 · AI
Adjuvant Development in the context of a vaccine to protect against tuberculosis$1,473,199
N01 · FY2020 · AI
Adjuvant Development Program$1,254,141
N01 · FY2012 · AI
Adjuvant Development in the context of a vaccine to protect against tuberculosis$1,170,507
N01 · FY2021 · AI
Vaccine development for SARS-CoV2$500,000
N01 · FY2020 · AI
High-throughput screening for novel adjuvant discovery for vaccines against influenza virus$413,000
N01 · FY2019 · AI
High-throughput screening for novel adjuvant discovery for vaccines against influenza virus$400,000
N01 · FY2016 · AI
High-throughput screening for novel adjuvant discovery for vaccines against influenza virus$320,000
N01 · FY2017 · AI